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Background : Sphere formation, one method for identifying self-renewal ability, has been used to report that cancer stem-like
cells exist in rat C6 glioma cells. Recent studies suggested that cancer stem-like cells share the stem cell properties of self-renewal
and multipotent ability of neural stem cells and might be regulated by microRNAs (miRNAs). However, the mechanism of miRNA
involvement in the sphere formation and neural differentiation abilities of cancer stem-like cells is poorly understood.
Results : We found that miRNA-30c could assist in sphere formation of C6 cells under defined conditions in neural stem cell
medium DMEM/F12-bFGF-EGF-B27. Moreover, overexpression of miRNA-30c might reduce 3-isobutyl-1-methylxanthine (IBMX)-
induced neural differentiation, as the expression of neural markers, especially glial fibrillary acidic protein (GFAP), decreased.
Further experiments revealed thatmiRNA-30c inhibited the IBMX-induced astrocyte differentiation via targeting the upstream genes
and inactivating phosphorylation of STAT3 of the JAK-STAT3 pathway. Subsequently, the expression of GFAP was reduced and the
number of astrocyte differentiation from C6 cells decreased. Conclusions: Our findings suggest that miRNA-30c could play a
regulatory role in self-renewal and neural differentiation in C6 glioma cells.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
A rat C6 glioma cell line was established by repetitively
administering N, N′-nitrosomethylurea to outbred Wistar
rats by Benda et al. (1968) and Schmidek et al. (1971).
Injecting these C6 cells into newborn rats induced tumors
that were consistent with glioblastoma multiforme (GBM) in
terms of pathology. Therefore, this C6 glioma cell line can be⁎ Corresponding author at: No. 1, Section 1, Jen-Ai Road, Taipei 100,
Taiwan. Fax: +886 2 23915292.
E-mail address: chien@ntu.edu.tw (C.-L. Chien).
http://dx.doi.org/10.1016/j.scr.2015.01.008
1873-5061/© 2015 The Authors. Published by Elsevier B.V. This
(http://creativecommons.org/licenses/by-nc-nd/4.0/).used for inducing an in vivo experimental astrocytomamodel in
rats (Auer et al., 1981), investigating the mechanism of tumor
growth, angiogenesis, and invasion, and designing anticancer
therapies (Abramovitch et al., 1995; Bernstein et al., 1990,
1991; Chicoine and Silbergeld, 1995; Nagano et al., 1993;
San-Galli et al., 1989). It also has been proved that C6 cells have
the attributes of self-renewal, multipotency, and tumorigenic-
ity, which are the characteristics of cancer stem-like cells
(Kondo et al., 2004; Shen et al., 2008; Zheng et al., 2007). In
these studies, the ability of self-renewal was characterized by
using “sphere formation” under culture conditions including
basic fibroblast growth factor (bFGF), epidermal growth factoris an open access article under the CC BY-NC-ND license
212 C.-C. Chao et al.(EGF), and B27 supplementation. These sphere cells were
further confirmed as “cancer stem-like cells” based on their
characteristics of multipotency and tumorigenicity.
Some reports suggested that microRNAs (miRNAs) can
function as regulators in cancer stem-like cells including GBM
tumors, hepatocellular carcinomas, and lung adenocarcinomas
(Bushati and Cohen, 2007; Calin and Croce, 2006a,b; Ciafre et
al., 2005; Godlewski et al., 2010; Murakami et al., 2006;
Yanaihara et al., 2006). MicroRNAs are noncoding sequences
that act as “post-transcriptional” regulators that bind to
complementary sequences in the 3′-untranslated regions of
target mRNA transcripts by imperfect base-pairing, usually
resulting in gene silencing (Alvarez-Garcia and Miska, 2005;
Bushati and Cohen, 2007). There is some evidence that miRNAs
are involved in neural development and tumor formation
(Alvarez-Garcia and Miska, 2005; Calin and Croce, 2006b;
DeSano and Xu, 2009; Fineberg et al., 2009; Hatfield and
Ruohola-Baker, 2008; Kosik, 2006). During neural develop-
ment, for example, loss of miRNA-9 suppresses proliferation
but promotes the migration of human neural progenitor cells in
vitro (Delaloy et al., 2010). Zhao et al. reported that
miRNA-219 and miRNA-338 were oligodendrocyte-specific
miRNAs in the spinal cord of mice, and function in part by
directly repressing negative regulators of oligodendrocyte
differentiation, including transcription factors Sox6 and Hes5
(Zhao et al., 2010).
Here, we demonstrate that a miRNA microarray served as
a good platform for investigating which miRNA contributes in
the processes of sphere formation and neural differentiation
in this glioma cell model. Spheres were formed at first to
enhance the potential for multipotency, and then neural
differentiation was induced by 3-isobutyl-1-methylxanthine
(IBMX) stimulation. Several miRNAs involved in sphere forma-
tion were identified by the miRNA microarray, and miRNA-30c
was confirmed to play an important role in sphere formation.
Furthermore, miRNA-30c suppressed the expression of glial
fibrillary acidic protein (GFAP) by affecting the JAK-STAT3
pathway. These results suggest that miRNA-30c has a regula-
tory role in self-renewal and neural differentiation.
Material and methods
Cell culture
A rat C6 glioma cell line was purchased from the Bioresource
Collection and Research Center (BCRC; Taiwan). Cells were
cultured in serum-containing or serum-free neural stem cell
medium at a density of 1 × 105 cells/dish. The serum-containing
medium was composed of Dubecco's modified Eagle's medium
(DMEM) (Life Technologies, Carlsbad, CA, USA), 10% fetal bovine
serum (FBS; Life Technologies) and penicillin–streptomycin
(Life Technologies). Cells were incubated at 37 °C under 95%
air, 5% CO2, and 100% humidity.
Sphere formation
C6 glioma cells were seeded on 6 cm petri dishes at 1 × 105
cells/dish (Becton Dickinson Labware, Franklin Lakes, NJ,
USA). Each dish contained 5 ml serum-free neural stem cell
medium DMEM plus F12 containing 20 ng/ml bFGF (Life
Technologies), 20 ng/ml EGF (Life Technologies), and 20 μl/ml B27 supplement (Life Technologies) (hitherto designated
DMEM/F12-bFGF-EGF-B27). Cells were incubated at 37 °C
under 95% air, 5% CO2, and 100% humidity. Fresh 200 μl lots of
serum-free neural stem cell medium were added every 24 h
and subculture the cells every 1 week for a minimum of 7
passages. After spheres were formed, cells were subsequently
cultured in serum-free neural stem cell medium for further
RNA and protein analysis. The samples of adherent cells,
spheres at 1st passage and spheres 2nd passage are indicated
as C6A, C6S-p1 and C6S-p2, respectively.
Western blot analysis
For preparing protein lysates, cells were washed in cold
phosphate-buffered saline (PBS), and then treated with RIPA
protein lysis buffer (150 mM NaCl, 1% NP-40, 0.5% deoxycholic
acid, 0.1% SDS, 50 mM Tris–HCl at pH 7.5, and 5 mM EDTA)
containing a cocktail of protease inhibitors (Roche Applied
Science, Mannheim, Germany). The cell debris was removed
by centrifugation at 14,000 × g for 30 min at 4 °C. The protein
concentration in the supernatants compared to standard
bovine serum albumin (BSA) concentrations was determined
using Bio-Rad protein assay kits (Bio-Rad, Hercules, CA, USA).
For each lane of 12% SDS-PAGE gel, 30 μg total proteins of cell
lysates was loaded, separated, and subsequently transferred
onto PVDFmembranes (Bio-Rad). Themembraneswere probed
with specific antibodies against βIII-tubulin (1:500, mouse
monoclonal, Sigma-Aldrich, St Louis, MO, USA), 2′, 3′-cyclic
nucleotide 3′-phosphodiesterase (CNPase; 1:500, mouse
monoclonal; Millipore, Billerica, MA, USA), GFAP (1:500,
mouse monoclonal; Sigma-Aldrich), nestin (1;1000, mouse
monoclonal; BD Biosciences, San Diego, CA, USA), sox2
(1:1000, rabbit polyclonal; Millipore), p-STAT3 (1;1000, rabbit
polyclonal; eBioscience, Inc, San Diego, USA) and STAT3
(1:1000, rabbit polyclonal; eBioscience). An anti-GAPDH anti-
body (1:25,000, mouse monoclonal; Millipore) was used to
probe the GAPDH internal control for equal loading of protein
lysates. Immunocomplexes were formed by incubation of the
proteins with primary antibodies overnight at 4 °C. Blots were
washed and incubatedwith peroxidase conjugated anti-mouse or
anti-rabbit secondary antibodies (GE Healthcare, Milwaukee, WI,
USA) for 1 h. Western blot results were detected using an
enhancedchemiluminescencewesternblotting system(Millipore)
and film autoradiography (Kodak, Rochester, NY, USA).
Immunofluorescent staining
Cells on poly-D-lysine-coated coverslips (Sigma-Aldrich) were
fixed with 4% paraformaldehyde (Sigma-Aldrich) in PBS (pH 7.4)
for 10 min. After washing three times with PBS, the cells were
then incubatedwith blocking buffer containing 10% normal goat
serum (Life Technologies) and 0.1% Triton X-100 (Sigma-Aldrich)
in PBS for 30 min at room temperature. After removing the
blocking buffer, sampleswere incubated overnightwith primary
antibodies against βIII-tubulin (1:1000, rabbit polyclonal IgG;
Sigma-Aldrich), GFAP (1:200, mouse monoclonal; Millipore) or
CNPase (1:200, mouse monoclonal IgG; Millipore) at 4 °C. After
washing the cells three times with PBS at room temperature,
cells were incubated with fluorophore-conjugated secondary
antibodies (Sigma-Aldrich) to recognize primary antibodies.
Hoechst 33342 (Sigma-Aldrich) was used to label DNA in the cell
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ture, cells weremounted in fluoromount G (ElectronMicroscopy
Science, EMS, Hatfield, PA, USA). Cells were visualized with a
Leica TCS SP5 confocal microscope (Leica Microsystems GmbH,
Wetzlar, Germany).
In vitro differentiation
To study neural differentiation, cells were initially seeded at a
density of 1 × 105 cells per 6 cm dish in serum-free neural stem
cell medium for 7 days to form spheres, then the spheres were
dissociated to single cells and plated in serum-free neural stem
cell culture medium for another 7 days. For studying the
induction of differentiation, serum-free neural stem cell
medium was replaced by induction medium, which contained
neurobasal medium, 2% FBS, B27 supplement, and IBMX
(Sigma-Aldrich) for another 3 days. The stock solution of IBMX
was prepared in DMSO (Sigma-Aldrich). During this period, the
medium was replaced with fresh induction medium every day.
RNA sample preparation
Total RNA with or without any drug treatment from C6A,
C6S-p1 and C6S-p2 was extracted using TRIzol reagent (Life
Technologies) and stored at −80 °C. All of the samples
underwent a check on the quality and the quantity of sample
RNA using an Agilent 2100 Bioanalyzer (Agilent Technologies,
Santa Clara, CA, USA) and the RNA 6000 nano kit according
to the manufacturer's instructions (Agilent Technologies).
Isolated total RNA was further analyzed by miRNA microar-
ray or converted to cDNA for real-time polymerase chain
reaction (PCR) analysis.
MicroRNA microarray screening
For this analysis, the febits biochip “Geniom® Biochip
microfluidic primer extension assay, MPEA, Rattus norvegicus”
was used (febit biomed GmbH, Heidelberg, Germany). The
probes were designed as the reverse complements of all major
mature miRNAs and miRNA star sequences as published in the
current Sanger miRBase release (version 14.0 September 2009,
http://microrna.sanger.ac.uk/sequences/index.shtml)
(Griffiths-Jones et al., 2008) for rats (R. norvegicus). Briefly,
sample labeling with biotin was carried out by microfluidic-
based enzymatic on-chip labeling of miRNAs by MPEA as
described (Vorwerk et al., 2008). Following hybridization for
16 h at 42 °C, the biochip was washed automatically and a
program for signal enhancement was processed with the
Geniom® RT Analyzer (febit biomed GmbH). The resulting
images were evaluated using the Geniom Wizard Software. For
each array, the median signal intensity was extracted from the
raw data file such that for each miRNA intensity, values were
calculated corresponding to each replicate copy of miRBase on
the array. Following background correction, the intensity values
of each miRNA were summarized by their median value.
Quantile normalization was applied to normalize the data
across different arrays, and all further analyseswere carried out
using the normalized and background subtracted intensity
values. A median value of each miRNA was obtained. To
compare the intensities of each miRNA in any pair of samples,
qmedian values were calculated as the ratio of median values inthe pair. Logqmedian values were calculated as log values of
qmedian values. The miRNAs with the C6S/C6A logqmedian
values higher than +2 or lower than −2 were listed in
Supplemental Table 1.
Expressions of microRNAs in C6 cells
To determine the effects of miRNA oligos on sphere formation
ability, cells were cultured in DMEM/F12-bFGF-EGF-B27 medi-
um overnight, then transfected with the 10 pmol of miRNA
oligos using the RNAiMAX transfection reagent (Life Technolo-
gies) and incubated at 37 °C under 5% CO2 in air for 1 week.
The miRNA oligos include miRNA-30c, anti-miRNA-30c, miR-
125bstar, anti-miR-125bstar and nontargeting controls (NC and
anti-NC, GenePharma, Shanghai, P. R. China). Sequences of the
miRNA oligos are shown in Table 1.
Cell proliferation assay
The WST-1 cell proliferation assay (Roche Applied Science,
Mannheim, Germany) was adapted to measure the prolifer-
ation of C6 spheres. Cells were seeded at 5000/well in a
96-well plate, and cultured in DMEM/F12-bFGF-EGF-B27
medium with or without miRNA oligos for quantification of
cell proliferation. WST-1 reagent was added to each well,
incubated at 37 °C for 4 h under 5% CO2 in air, and then
plates were shaken for 1 min. Plates were analyzed optically
at 450 nm with a reference wavelength at 600 nm using a
microplate multiscan FC ELISA reader (Thermo Fisher
Scientific, Waltham, MA, USA).
Construction of miRNA-30c inducible vector and
establishment of stable cell lines
The miRNA-30c of double-stranded oligonucleotides was
generated for cloning into the lentiviral vector pTRIPz
which contained a turbo-red fluorescent protein (turboRFP)
sequence as a reporter gene (Open Biosystems; Thermo
Fisher Scientific) according to the manufacturer's instruc-
tions. All of these constructs were verified by sequence
analysis. The empty vector was used as a control.
Subconfluent cells were harvested and resuspended in
fresh culture medium at 1 × 107 cells/ml and mixed with
0.5 μg of the constructed plasmids. Then, electroporation
was performed using an ECM830 electroporation system
(BTX, San Diego, CA, USA) using the LV mode program
recommended by the manufacturer as follows: one pulse at
190 V for 70 ms. After electroporation, cells were plated on
a 10 cm culture dish and placed at 37 °C under 5% CO2 in air
for 2 weeks. Cells were selected with puromycin (Merck &
Co., Inc., Whitehouse Station, NJ, USA) for 14 days.
Individual clones were isolated, and cells were incubated
in the absence or presence of doxycyclin (dox) and 1 μM
pyridone 6 (a jak inhibitor, Millipore) for real-time PCR,
Western blot and immunofluorescent staining.
Real-time PCR analysis
For real-time PCR, miRNAs were elongated in a poly-
adenylation reaction and then reverse transcribed to
Table 1 Sequences of miRNA oligos and primers.













214 C.-C. Chao et al.miRNA first-strand cDNA according to the manufacturer's
instructions (Agilent Technologies). Total RNA was reverse
transcribed to first-strand cDNA using oligo-dT primers provided
in the ThermoScript™ RT-PCR System (Life Technologies). The
primers for genes (jak1, socs3, and pik3cd) are shown in Table 1.
Real-time PCR was carried out on cDNA using Brilliant II SYBR
Green QPCR Master Mix Kits with low Rox (Agilent Technologies)
in MX3000P PCR cycler (Agilent Technologies). All reactions
were performed in 25 μl volumes using the following PCR
program: initial denaturation at 95 °C for 10 min, 40 amplifi-
cation cycles at 95 °C for 30 s, 60 s at 60 °C, and 60 s at 72 °C.
PCR with pure water instead of the template was used as a
negative control. Specificity was verified by melting curve
analysis and agarose gel electrophoresis. The threshold cycle
values of each sample were used in the post-PCR data analysis.
GAPDH was used as an internal control for normalization of
mRNA levels.Statistical analysis
The experiments were repeated 3 times and the results of a
typical experiment are shown. The experimental data were
presented as the mean ± SEM and were evaluated for
significance by unpaired Student t-test. Statistical signifi-
cance was established at a level of p b 0.05.Results
Sphere formation and multipotency of C6 cells
To investigate the sphere-forming ability of C6 cells, cells were
incubated in serum-free neural stem cell medium containing
bFGF, EGF, and B27 supplement for 7 days. Morphological
examinations of C6 cells cultured under adherent and sphere
culture conditions are shown in Supplementary Fig. 1A. In the
adherent culture condition, C6 cells showed fibroblast-like
morphology (Supplementary Fig. 1A-1), whereas in sphere
culture conditions some of the cells formed spheroids and
others attached to the bottom of the dish (Supplementary Fig.
1A-2). Besides, immunoreactivities of sox2 and nestin deter-
mine by western blot showed that these two neural stem/
progenitor markers expressed in adherent cells and sphere
culture till at least passage 7. Protein expression patterns ofSox2, nestin (markers for neural stem cell), βIII-tubulin (a
marker of neuron), GFAP (an astrocyte marker), and CNPase (a
marker of oligodendrocytes) were examined for differentiation
potency of C6 cells in adherent and sphere forms. Usingwestern
blot analysis, few immunocomplexes of neural markers were
detected in adherent cells, whereas elevated protein levels of
βIII-tubulin, GFAP, and CNPase were observed in spheres
(Fig. 1A). C6 cells without differentiation induction remained
spheroid morphology (Supplementary Fig. 1C-4). Immunoreac-
tivities of GFAP and CNPase, but not βIII-tubulin could be
detected by immunocytochemistry of these non-induced C6
sphere cells (Supplementary Figs. 1C-5 and C-6). The results
indicated that sphere formation not only promoted the ability
of self-renewal (Q. Xu et al., 2009) but also enhanced
multipotency.
Differential expression of miRNAs in C6S versus
C6A samples
Microarray analysis was performed to identify the miRNAs
involved in C6 sphere formation. There are 388 distinct miRNAs
included on the array. In C6S cells, 24 miRNAs were obviously
upregulated as the C6S/C6A logqmedian values (either C6S-p2/
C6A or C6S-p1/C6A) were more than 2 (Supplemental Table 1).
2 miRNAs (miRNA-653 and miRNA-487b) were expressed at
much lower levels in the spheres than in the C6 adherent cells.
Furthermore, we would like to identify the miRNAs that
maintained consistent high levels upon sphere passages. Thus,
themiRNAswith C6S-p2/C6S-p1logqmedian values close to zero
were selected. Among thesemiRNAs,miRNA-30c remained high
expression levels to at least 7 passages (Fig. 1B)when compared
with other chosen miRNAs, such as miR-125bstar. MiRNA-30c
has been reported to contribute to developmental processes
including osteo differentiation, skeleton formation, adipocyte
differentiation, angiogenesis and hepatobiliary (Bridge et al.,
2012; Gao et al., 2011; Hand et al., 2009; Karbiener et al.,
2011; Vimalraj and Selvamurugan, 2014; Zhang et al., 2012).
This study is the first time to report the involvement of
miRNA-30c in sphere formation and neural differentiation.
The effects of miRNA-30c oligos in C6 cells
Either miRNA-30c or anti-miRNA-30c oligos were transfected
into C6 cells cultured in DMEM/F12-bFGF-EGF-B27 medium.
Figure 1 Neural differentiation markers and miRNA expression profiles of adherent and sphere C6 cells during culture passage.
(A) Western blot data showed that the expression of βIII-tubulin, GFAP, and CNPase was relatively weak in the adherent cells when
compared with the ones in sphere cells, indicating the potential for multipotency in sphere cells. The expression of GAPDH was used
as an internal control. (B) Real-time PCR analysis was performed to confirm the increased expression of miRNA-30c in the adherent
and sphere C6 cells. The expression of miRNA-125bstar is shown as an example of other selected miRNA from the microarray.
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and others attached to the bottom of the dishes, showing
normal adherent morphology (Fig. 2G). Most C6 cells formed
spheres after miRNA-30c treatment (Fig. 2A). The morphol-
ogy of C6 cells with anti-miRNA-30c treatment was similar to
control cells (Fig. 2D). As for the control group, there were
no significant effects on sphere formation of C6 cells after
NC or anti-NC transfection (Figs. 2C and F). Statistical
analysis of the cell proliferation assay results showed that
there was no significant difference between the growth rate
of the treated and control groups (Fig. 2H).Overexpression of miRNA-30c in C6 cells
To determine the effects of miRNA-30c on C6 neural differen-
tiation, we constructed a miRNA-30c-inducible plasmid. Thisconstruct contained a turbo-red fluorescent protein (turboRFP)
sequence as a reporter gene. We then transfected the plasmid
into C6 cells and established a stable cell line, named miRNA-
30c/C6 cells. The miRNA-30c overexpressing cells formed red
sphereswhen cultured in DMEM/F12-bFGF-EGF-B27medium. By
contrast, the morphology of vector-treated control cells was
similar to C6 parental cells and lacked turboRFP protein
expression (Supplementary Fig. 2A). Real-time PCR analysis of
miRNAs showed an apparent increase of miRNA-30c expression
in dox-induced sphere cells (Supplementary Fig. 2B).
MiRNA-30c overexpressing C6 (miR-30c/C6) cells with
doxycycline induction were cultured under sphere-forming
condition till at least passage 7. The expression of the neural
differentiation markers and miRNAs in the cells was charac-
terized by western blot. The results showed that βIII-tubulin,
GFAP, andCNPasewere expressed less in adherentmiR-30c/C6
cells than their average expression levels in sphere cells,
Figure 2 The effects of miRNA oligos on morphology and proliferation ability of C6 cells. C6 cells were cultured in DMEM/
F12-bFGF-EGF-B27 medium with (A) miRNA-30c, (B) miR-125bstar, (C) NC (negative control), (D) anti-miRNA-30c, (E) anti-miR-125bstar,
(F) anti-NC or (G) without treatments (control) for 7 days. In the control group, in addition to forming spheres, some cells attached to the
bottom of dishes and showed normal adherent morphology. Spheres were observed following treatment with miRNA-30c. The
morphologies of C6 cells were similar to the control group when treated with anti-miRNA-30c, miR-125bstar, anti-miR-125bstar, NC, and
anti-NC. Scale bar = 100 μm. (H) Cell proliferation assay of C6 cells treated with miRNA oligos.
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During cell subculture, the expression level of GFAP and
CNPase decreased, and increased levels of sox2, nestin and
βIII-tubulin were observed with the existence of miRNA-30c
overexpression. The expression of turboRFP was the control of
miRNA-30c expression. Real-time PCR analysis confirmed that
miRNA-30c expressed in the miR-30c/C6 sphere cells (Fig. 3B).Neural differentiation of C6 cells
Neural differentiation of C6 cells was induced by IBMX, and the
expressions of neural markers, including βIII-tubulin, GFAP, and
CNPase,were analyzed bywestern blotting (Supplementary Fig.
2C). We found that these three neural markers were expressed
in higher levels in sphere cells compared with adherent cells.
The expression levels of these three markers were furtherincreased after IBMX-induced neural differentiation. In sphere
cells overexpressing miRNA-30c, the levels of βIII-tubulin and
GFAP became lower than in sphere cells with no such
overexpression. After IBMX treatment, βIII-tubulin and GFAP
expressions in sphere cells were raised. However, the expres-
sion levels of these proteins were lower in the dox-induced cells
when compared with the cells without dox induction. Further-
more, there was no significant increase in CNPase expression in
sphere cells or IBMX-treated cells when compared with the C6A
group. Immunofluorescent staining revealed positive results for
βIII-tubulin, GFAP, and CNPase in control and miRNA-30c-
transfected cells following IBMX treatment, but without dox
induction. Thus, IBMX could induce C6 parental cells and
miRNA-30c-transfectant cells to differentiate into neuronal
cells (Figs. 4A, B), astrocytes (Figs. 4D, E), and oligodendrocytes
(Figs. 4G, H) without the need for dox treatment. However, in
the IBMX-treated miRNA-30c-overexpressing cells, the numbers
Figure 3 Neural differentiation markers and miRNA expression profiles of miR-30c/C6 cells. (A) Western blot data showed that
βIII-tubulin, GFAP, and CNPase were expressed less in adherent miR-30c/C6 cells than the average expression levels in sphere cells,
indicating the potential for multipotency in sphere cells. The expression level of GFAP and CNPase decreased, and increased levels of
sox2, nestin and βIII-tubulin were observed during subculture. The expression of RFP was the miRNA-30c expression control and
GAPDH was used as an internal control. (B) Real-time PCR analysis was performed to examine the expressions of miRNA-30c and
miRNA-125bstar in the adherent and sphere cells in C6 adherent cells (C6-Ad), miR-30c/C6 adherent cells (30c-Ad) and miR-30c/C6
sphere cells (S-p1–S-p7).
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(Fig. 4F) were reduced, but no significant effect on CNPase-
positive cells was seen (Fig. 4I). Thus, miRNA-30c overexpres-
sion showed the ability to induce impairment of neural
differentiation, especially neurogenesis and astrogenesis. Be-
sides, IBMX can upregulate intracellular cAMP levels thereby
possibly activating the protein kinase A (PKA) pathway (Seternes
et al., 1999) and accelerate the initiation of differentiation.
Thus, IBMX treatment was conducted to test the differentiation
ability of C6 cells. The differentiation patterns of C6 sphere
cells with and without IBMX-induction were demonstrated by
morphology and immunostaining of the molecular markers.After 2-day IBMX treatment on C6 spheres, most cells began to
show a neuronal-like morphology, such as bipolar or multipolar
processes (Supplementary Fig. 1C-1). GFAP, CNPase, and
βIII-tubulin could be detected in some differentiated cells
using immunofluorescent staining (Supplementary Figs. 1C-2
and C-3).Possible pathway
Takanaga et al. reported in 2004 that rising cytoplasmic
cAMP could activate the protein kinase A and protein kinase
Figure 4 The neural differentiation induced by IBMX in C6 and miRNA-30c/C6 cells demonstrated by immunofluorescence staining.
Immunoreactivities for (A–C) βIII-tubulin, (D–F) GFAP, and (G–I) CNPase could be detected after IBMX induction. The expression
levels of βIII-tubulin and GFAP were inhibited in dox-treated miRNA-30c/C6 cells (C and F). Scale bar = 25 μm.
218 C.-C. Chao et al.C pathways and that the JAK-STAT3 pathway could be
activated indirectly (Takanaga et al., 2004). Thus, p-STAT3
expression was increased along with GFAP expression. Our
western blotting data confirmed that C6 spheres overexpressed
GFAP following IBMX induction (Fig. 6A). However, GFAP
expression was inhibited when the cells were treated with
miRNA-30c. Therefore, we further examined how miRNA-30c
overexpression might affect the expression of p-STAT3 by
western blotting analysis. The expression of p-STAT3 was
induced in IBMX-induced sphere cells lacking miRNA-30c
expression, whereas a lower p-STAT3 protein level was shown
when miRNA-30c-overexpressing cells were stimulated with
IBMX. The changes of p-STAT3 were similar to the trend of
GFAP changes upon IBMX-induced differentiation (Fig. 5). It is
possible that some miRNA-30c-related candidate target
genes exist in the JAK-STAT3 signaling pathway. The
bioinformatics tool RNAhybrid (http://bibiserv.techfak.
uni-bielefeld.de/renhybrid/) was employed to identify theJAK-STAT3 pathway-related genes: pik3cd, socs3, and jak1.
Real-time PCR analysis of genes inmiR-30c/C6 cells showed that
in adherent cells, the mRNA levels of socs3 and pik3cd genes in
miRNA-30c/C6 cells without dox treatment were lower than in
the cells treated with dox. On the contrary, the expression of
jak1was increased in themiRNA-30c-overexpressing C6 cells. In
sphere cells, all these three gene expression levels were
decreased in dox-induced miRNA-30c/C6 cells compared with
cells lacking dox treatment. Similar to the results for adherent
cells, the mRNA expression levels of pik3cd and socs3 were
decreased and jak1 expression was increased in the IBMX-
treated, miRNA-30c overexpressing cells. After anti-miRNA-30c
oligo treatment, increased expression levels in all these
genes compared with the dox-induced miRNA-30c/C6 cells
(Figs. 5B–D).
Furthermore, pyridine 6 (a selective Jak1 inhibitor) was
used to examine if the inhibition to JAK-STAT pathway might
have similar effects with miRNA-30c. Cells were cultured in
Figure 5 Protein and mRNA expression patterns of p-STAT3 and STAT3 in C6 and miR-30c/C6 cells after IBMX induction. (A) Western
blot data showed that the expression of p-STAT3 and total STAT3 could be detected in IBMX-induced cells. Overexpression of
miRNA-30c (+dox) suppressed the protein expression of p-STAT3. The expression of GAPDH was an internal control. (B)–(D) Real-time
PCR analysis showed that jak1, socs3, and pik3cd were detected in C6 and miR-30c/C6 inducible cells. In adherent cells,
overexpression of miRNA-30c reduced the mRNA expression of socs3 and pik3cd, while the mRNA levels of jak1 was increased. In
sphere cells, overexpression of miRNA-30c resulted in decreased expression levels in all these three genes compared with control
cells. After IBMX treatment, overexpression of miRNA-30c decreased the mRNA expressions of socs3 and pik3cd, whereas it increased
the expression of jak1. After being treated with anti-miRNA-30c oligos, increased expression levels in all these genes compared with
the dox-induced miRNA-30c/C6 cells (**, p b 0.01, unpaired t-test, n = 3).
219The role of microRNA-30c in the self-renewal and differentiation of C6 glioma cellscontrol medium without any treatment, pyridone 6, IBMX or
IBMX plus with pyridine 6 for 2 days. Protein lysates were
extracted for western blot analysis. The results showed that
increasing expression of p-STAT3 could be detected in
IBMX-induced cells. Downregulated protein expression levels
of GFAP and p-STAT3 in cells after treated with pyridine 6
indicating that astrocyte differentiation were regulated by
JAK-STAT3 pathway activation (Fig. 6).Discussion
Here, we report that rat C6 glioma cells could form spheres
in serum-free medium containing bFGF, EGF, and the B27
supplement and differentiate into three different cell
lineages: neurons, astrocytes, and oligodendrocytes after
IBMX induction. These results are consistent with previousreports suggesting that C6 cells might have the abilities of
self-renewal and multipotency (Kondo et al., 2004; Zheng et
al., 2007): namely the characteristics of cancer stem-like
cells. In serum-free medium containing bFGF and EGF,
sphere formation is a simple and effective method for the
isolation and enrichment of cancer stem-like cells in human
and murine cell lines as well as rat C6 cells (Pellegatta et al.,
2006; Yu et al., 2008). The increased expression of neural
markers in both sphere cells and IBMX-induced sphere cells
indicated that the ability for neural differentiation could be
induced in sphere-forming cells. These results were consis-
tent with the studies of Kondo et al. (2004) and Yu et al.
(2008). In summary, sphere-forming cells can be enriched in
C6 cells and can differentiate into neural cells including
neurons, astrocytes, and oligodendrocytes.
AmiRNAmicroarray was applied for investigating the effects
of miRNAs in sphere formation in C6 cells. Supplemental Table 1
Figure 6 Decreasing of GFAP expression by through blocking of Jak-STAT3 pathway. MiR-30c/C6 cells were cultured in control
medium without any treatment ((–)), pyridone 6 (p, a selective Jak1 inhibitor), IBMX or IBMX plus with pyridine 6 (IBMX + p) for
2 days. Protein lysates were extracted for western blot analysis (A). The results showed that increasing expression of p-STAT3 could
be detected in IBMX-induced cells. Downregulated protein expression levels of GFAP and p-STAT3 in cells after being treated with
pyridone 6 indicating that astrocyte differentiation were regulated by JAK-STAT3 pathway activation. The expression of GAPDH was
an internal control. (B–E) Relative signal intensities for βIII-tubulin (B), GFAP (C), CNPase (D) and p-STAT3 (E) in the western blot
analysis. Increased expression of βIII-tubulin, GFAP, CNPase and p-STAT3 were shown in control and miRNA-30c-overexpressed cells
after IBMX stimulation except GFAP expression in miRNA-30c-induced cells. Only expression of GFAP and p-STAT3 were impeded when
IBMX-treated cells were incubated under the existence of pyridone 6 (**, p b 0.01, unpaired t-test, n = 3).
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221The role of microRNA-30c in the self-renewal and differentiation of C6 glioma cellsshows that 24 miRNAs were upregulated and two were
downregulated in sphere-forming cells compared with adher-
ent cells. Most of these miRNAs play a suppressive role in
carcinogenesis. MicroRNA-9 is highly expressed in glioma cells,
and inhibits cell proliferation by targeting CREB, a target of
miRNA-9, suggesting the possibility of a “miRNA-9–CREB”
minicircuitry involved in coordinating the proliferation of
glioma cells (Tan et al., 2012). MicroRNA-146a inhibits cell
growth, cell migration, and induces apoptosis in non-small-
cell lung cancer cells (Chen et al., 2013). It acts as a native
safeguarding mechanism to restrict the formation of glioma
stem-like cells and glioma growth by directly controlling the
expression of Notch1 (Mei et al., 2011). MicroRNA-34a acts as a
putative tumor suppressor by inhibiting cell proliferation
through mediating gene expression of notch1 in GBM (Li et
al., 2011). In glioma cells, overexpressed miRNA-26a might
play a vital role in promoting tumor growth and angiogenesis
by suppressing PHB and the downstream AKT and ERK
pathways (Qian et al., 2013). By targeting OCT4, miRNA-145
suppresses lung adenocarcinoma-initiating cell proliferation
(Yin et al., 2011). Furthermore, some of these miRNAs are
associated with cell differentiation. For example, miRNA-9
plays a regulatory role that coordinates the proliferation and
migration of human neural progenitor cells (Delaloy et al.,
2010). In addition, miRNA-9 might be involved in neural stem
cell self-renewal and differentiation by suppressing TLX ex-
pression, inhibiting neural stem cell proliferation, and acceler-
ating neural differentiation (Zhao et al., 2009). Overexpression
ofmiRNA-204 inhibited osteoblast differentiation and promoted
adipocyte differentiation by directly targeting Runx2 in
mesenchymal progenitor cells and bone marrow stromal cells
(Huang et al., 2010). MicroRNA-199a-5p and miRNA-145 were
shown to be involved in oligodendrocyte development by
mediating C11Orf9 repression (Letzen et al., 2010). MicroRNA-
145 has also been reported to play an important role in human
stem cell growth and differentiation by regulating OCT4, SOX2,
and KLF4 (N. Xu et al., 2009). During neuronal development,
miRNA-34a plays a role in hippocampal spinal morphology and
electrophysiological change through the Tap73/miRNA-34a axis
in mouse embryonic stem cells (Agostini et al., 2011). In this
study,we found that thesemiRNAswere upregulatedwhen cells
formed spheres in DMEM/F12-bFGF-EGF-B27 medium, indicat-
ing that these miRNAs might play regulatory roles in cancer
progression and differentiation.
It is the first time to report the involvement of miRNA-30c
in enhancing sphere formation and neural differentiation.
The relationships of miRNA-30c and osteodifferentiation and
adipocyte differentiation have been discussed previously
(Gao et al., 2011; Karbiener et al., 2011; Vimalraj and
Selvamurugan, 2014). We will further analyze if miR-30c-
overexpression affects the expression of miR124a or miR9
(miRNAs known to play a key role in neurogenesis) and
miRNA-199a-5p and miRNA-145 (oligodendrocyte develop-
ment). The protein expression level of GFAP was inhibited in
miRNA-30c-overexpressing sphere cells after IBMX induction
compared with the control group. By elevating the level of
intracellular cAMP, IBMX is known to induce the astrocytic
differentiation of C6 glioma cells by activating the JAK-STAT
pathway (Bonni et al., 1997; Takanaga et al., 2004). In the
present experiments, the protein level of p-STAT3 was also
decreased in miRNA-30c-overexpressing IBMX-induced C6
sphere cells. In Moorthi's report, the JAK-STAT3 pathway wasaffected by miRNA-30c, suggesting that target genes might
exist in this pathway (Moorthi et al., 2013). Here, pik3cd,
socs3, and jak1, the putative target genes for miRNA-30c in
the JAK-STAT3 pathway, were examined by real-time PCR. The
decreased mRNA levels of pik3cd and socs3 might explain the
inhibited p-STAT3 expression in miRNA-30c-overexpressing
IBMX-induced C6 cells (Fig. 7). Qin et al. reported that the
activation of STAT3 leads to SOCS3 expression in astrocyte
cultures (Qin et al., 2008). In Baker's study, oncostatin M
stimulated cultured astrocytes and induced SOCS3 expression;
the expression decreased with time and p-STAT3 showed
similar expression pattern as SOCS3 (Baker et al., 2008). When
SOCS3 was expressed in neural stem cells, the number of
MAP2-positive cells increased and the number of GFAP-positive
cells decreased, indicating that overexpression of SOCS3 can
regulate neurogenesis and astrogenesis in neural stem cells
(Cao et al., 2006). These results might help us to identify the
miRNA-30c-regulated target genes acting during neural
differentiation.
Conclusions
In summary, we have provided evidence that miRNA-30c
plays an important role in sphere formation and neural
differentiation in glioma cells. Although the interactions
between miRNA-30c and its related genes are not yet clear,
this study might offer a new way to examine the regulatory
role of miRNAs in the progression of gliomas.
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